Showing results (1701-1710 of 2,383) with videos related to

Sort By:
Pageof 239
Blood|June 20, 1998
A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031)J E Godwin, K J Kopecky, D R Head, et al.
Blood|November 15, 1991
Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogsF G Schuening, K Kawahara, A D Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate modelEneida R Nemecek, Donald K Hamlin, Darrell R Fisher, et al.
Community Mental Health Journal|January 4, 2022
Feasibility and Utility of Different Approaches to Violence Risk Assessment for Young Adults Receiving Treatment for Early PsychosisStephanie A Rolin, Jennifer Scodes, Renald Dambreville, et al.
Blood|December 1, 1986
Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factorsH J Deeg, S Self, R Storb, et al.
The Journal of ECT|June 7, 2003
Decisional capacity of severely depressed patients requiring electroconvulsive therapyMaria I Lapid, Teresa A Rummans, Kristine L Poole, et al.
Journal of Clinical Microbiology|August 31, 2002
Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzaeMichael R Jacobs, Saralee Bajaksouzian, Anne Windau, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 31, 2000
Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study resultsP L Weiden, H B Breitz, O Press, et al.
Cancer|August 15, 1988
A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patientsG L Messerschmidt, R Makuch, F Appelbaum, et al.
British Journal of Haematology|March 4, 2014
SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemiaAnjali S Advani, Shannon McDonough, Steven Coutre, et al.
Pageof 239